|
GB964989A
|
|
Medicines containing a cysteine derivative
|
|
US3033882A
|
|
Octanoic esters and processes for their preparation and utilization
|
|
US2966520A
|
|
Production of bis-chloromethyl bisulphide
|
|
GB825347A
|
|
Improvements in the production of bis-chloromethyl bisulphide
|
|
ES236277A2
|
|
System synthesis procedure (Machine-translation by Google Translate, not legally binding)
|
|
GB815197A
|
|
Process for the production of bis(chloromethyl) disulphide
|
|
US2894039A
|
|
Process for the production of bis (chloromethyl)disulphide
|
|
GB825178A
|
|
Improvements in or relating to therapeutically active compositions containing cysteine compounds
|
|
US2944065A
|
|
Bis amino ethyl disulphide compounds
|
|
ES232160A1
|
|
Synthesis procedure of cistina (Machine-translation by Google Translate, not legally binding)
|
|
GB807849A
|
|
Improvements in or relating to the production of cystine
|
|
GB807850A
|
|
Improvements in or relating to bis amino and n-acylated amino ethyl disulphide compounds
|
|
GB797507A
|
|
Improvements in or relating to therapeutically valuable cysteine compounds
|
|
GB797508A
|
|
Improvements in or relating to therapeutically valuable cysteine compounds
|
|
ES220990A1
|
|
Procedure for obtaining gelatin royale from bees in a pure and good conservation form (Machine-translation by Google Translate, not legally binding)
|
|
ES220540A3
|
|
A procedure to obtain gelatine royale of bees in a pure and good conservation form (Machine-translation by Google Translate, not legally binding)
|
|
CA661922A
|
|
Therapeutic compositions
|
|
CA661923A
|
|
Acetylsalicylic acid - polysiloxane compositions
|
|
CA577531A
|
|
Production of cystine
|
|
CA596525A
|
|
Bis amino ethyl disulphide compounds
|
